Trial Profile
Bupivacaine 1.3% Liposomal Suspension (Exparel) vs Continuous Perineural Ropivacaine Infusion in the Management of Post-operative Pain Following Total Shoulder Arthroplasty; An Open-label, Randomized, Controlled Study
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary) ; Ropivacaine
- Indications Postoperative pain
- Focus Therapeutic Use
- 07 Feb 2018 Status changed from active, no longer recruiting to discontinued.
- 04 Jun 2016 New trial record